To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors

NCT02410174 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor Accural

Conditions

Primary Tumor
Renal Cell Carcinoma

Interventions

RADIATION: Stereotactic Body Radiotherapy (SBRT)

Sponsor

Beth Israel Medical Center